Gilead Faces HIV Drug Injury Lawsuit Filed On Behalf of Nearly 150 Plaintiffs

Nearly 150 individuals have joined together in a product liability lawsuit filed last week against Gilead, alleging that they suffered bone fractures, kidney problems and other injuries caused by side effects of HIV drugs like Truvada and Atripla.

The complaint (PDF) was filed in the U.S. District Court for the Northern District of California on on March 17, indicating that Gilead knew that the drugs were toxic to kidneys and bones, yet failed to provide adequate warnings for consumers and the medical community. The drug maker is also accused of withholding safer alternative treatments, waiting years to introduce less toxic versions of the HIV drugs, until patent protections were set to expire, which would impact sales of the blockbuster treatments.

Each of the plaintiffs indicate that they suffered renal failure, kidney injury, bone loss, fractures or other complications associated with bone deterioration following exposure to tenofovir disoproxil fumarate (TDF) based HIV drugs sold by Gilead in recent years, including Viread, Truvada, Atripla, Complera and Stribild.

HIV DRUGS LAWSUITS

Were you or a loved one prescribed Truvada or other HIV drugs?

Gilead HIV drugs Truvada, Atripla, Stribild, Viread and Complera have been linked to increased risks of kidney and bones injuries. Lawyers are actively reviewing cases for individuals who have suffered injuries.

Learn More About this Lawsuit See If You Qualify For Compensation

According to the lawsuit, Gilead has known for years that a less toxic version of the drugs could be developed, involving the antiviral tenofovir alafenamide fumarate (TAF), yet the drug maker continued to sell the more toxic versions without adequate warnings. It was only when generic equivalents were about to diminish sales that the drug maker introduced TAF-based drugs, marketing them as safer than the toxic TDF-drugs they had sold for years.

Plaintiffs allege that the decision to withhold development of TAF-based drugs was part of a scheme intended to allow Gilead to maintain an essential monopoly on HIV treatments until at least 2032. However, as a result of this decision to place profits before consumer safety, thousands of individuals nationwide have been left with severe injuries that may have been avoided.

“In addition to withholding safer designs, Gilead failed to adequately warn physicians and patients about the risks and safe use of TDF,” the lawsuit states. “Gilead provided only the weakest, inadequate warnings to doctors and patients about the need for frequent monitoring of all patients for TDF associated kidney and bone damage—preventing doctors from detecting early signs of TDF toxicity.”

The lawsuit joins a growing number of complaints filed by plaintiffs nationwide, who say they suffered Gilead HIV drug side effects. Most of the complaints are currently pending in California state court, but a growing number have also been filed in various federal district courts nationwide over the past year.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Abbott May Remove Infant Formula for Preemies Off the Market Due to Similac NEC Lawsuits
Abbott May Remove Infant Formula for Preemies Off the Market Due to Similac NEC Lawsuits (Posted today)

Abbott Laboratories is considering removing Similac infant formula products designed for preterm babies from the market, as it faces hundreds of lawsuits claiming the products increase the risk of necrotizing enterocolitis, which puts newborns at a high risk of permanent injuries and death.

Information About Suboxone Dental Claims To Be Exchanged By Parties in MDL
Information About Suboxone Dental Claims To Be Exchanged By Parties in MDL (Posted yesterday)

A federal judge has ordered parties involved in Suboxone dental decay lawsuits to submit proposals for exchanging information that will guide the selection of representative bellwether claims for early test trials.

Master Baby Food Lawsuit Filed in MDL Outlines How Toxic Metals Caused Autism, ADHD in Children
Master Baby Food Lawsuit Filed in MDL Outlines How Toxic Metals Caused Autism, ADHD in Children (Posted 4 days ago)

Plaintiffs have submitted a baby food lawsuit Master Complaint that is expected to streamline the filing of lawsuits alleging that toxic heavy metals in Beech-Nut, Gerber, Hain and Nurture products caused ADHD, autism and other developmental disorders.